Galmed Pharmaceuticals
(NASDAQ:GLMD)
$0.3793
0.0021[0.56%]
At close: Apr 18
$0.3793
0[0.00%]
PreMarket: 4:01PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commerc...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GLMD

FAQ

Q

How do I buy Galmed Pharmaceuticals (GLMD) stock?

A

You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galmed Pharmaceuticals's (GLMD) competitors?

A

There are no as such competitors for Galmed Pharmaceuticals.

Q

What is the target price for Galmed Pharmaceuticals (GLMD) stock?

A

The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Maxim Group on Monday, July 24, 2023. The analyst firm set a price target for 4.00 expecting GLMD to rise to within 12 months (a possible 954.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Galmed Pharmaceuticals (GLMD)?

A

The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $0.3793 last updated April 18, 2024 at 4:01 PM EDT.

Q

Does Galmed Pharmaceuticals (GLMD) pay a dividend?

A

There are no upcoming dividends for Galmed Pharmaceuticals.

Q

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

A

Galmed Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 30, 2024.

Q

Is Galmed Pharmaceuticals (GLMD) going to split?

A

There is no upcoming split for Galmed Pharmaceuticals.

Q

What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

A

Galmed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.